The bioassay-guided fractionation of the n-hexane extract of Citrus reticulata Blanco (Rutaceae) stem bark yielded scoparone (1), xanthyletin (2), lupeol (3), β-amyrin (4), stigmasterol (5), β-sitosterol (6) and palmitic acid. The structures of these compounds were determined by comprehensive spectroscopic analyses, i.e., 1D and 2D NMR and EI-MS, and by comparison with the reported data. Extracts, fractions and isolated compounds 1-6 were assessed for cytotoxicity by the 3-(4,5-dimethylthiazol-2-yl)-2,5-dphenyltetrazolium bromide (MTT) assay against three human cancer cell lines, i.e., human lung adenocarcinoma cell line A549, human breast adenocarcinoma cell line MCF7 and human Caucasian prostate adenocarcinoma cell line PC3. Significant activity of the n-hexane and the dichloromethane extracts was observed against the breast cancer cell line MCF7 with IC 50 s of 45.6 and 54.7 μg/mL, respectively. Moreover, the 70% ethyl acetate in n-hexane chromatographic fraction showed significant activity displaying IC 50 values of 53.0, 52.4 and 49.1 μg/mL against the cancer cell lines A549, MCF7 and PC3, respectively. Encouragingly, an IC 50 of 510.0 μg/mL against the human normal prostate cell line PNT2 indicated very low toxicity and hence favourable selectivity indices for the 70% ethyl acetate in n-hexane fraction in the range of 9.6-10.4 towards cell lines A549, MCF7 and PC3. Because compounds isolated from the above fraction only delivered IC 50 values in the range of 18.2-96.3, 9.2-34.1 and 7.5-97.2 μg/mL against A549, MCF7 and PC3 cell lines, respectively, synergistic action between compounds is suggested. Bioassay results valorize the anticancer effectivity of the stem bark of this plant in Cameroonian pharmacopoeia.
INTRODUCTION
Citrus reticulata Blanco (Rutaceae) or mandarin originates from China and was introduced to Africa and Europe via the Northern African route between the 15th and 19th century through trade with Portuguese and British Asian colonies (Ramón-Laca, 2003) . In Cameroon, the plant conquered all habitats and can nowadays even be found disseminated in the Cameroonian rainforest. The medicinal potential of its bark against tumours had been recognized early on by medicinal practioners.
Because fruits of Citrus species are used worldwide in traditional medicine for a wide range of conditions, including cancer prevention, treatment of flu, inflammation and more generally in healing and strengthening of the body, their pharmacological potential had been widely investigated during recent decades, resulting in hundreds of publications. The hydroxylated polymethoxyflavones 5-hydroxy-6,7,8,3 0 4 0 -pentamethoxyflavone and 5-hydroxy-3,6,7,8,3 0 4 0 -hexaamethoxyflavone isolated from the peel display strong inhibitory activity against the proliferation of the human promyelocytic leukaemia cell line HL60 and induce apoptosis (Li, Sun, Zhang, et al., 2007) . Hesperidin, also isolated from the peel, showed pronounced activity against larynx, breast and liver carcinoma cell lines (Al-Ashaal and El-Sheltawy, 2011) . Inhibition of human lung cancer cell lines H1299, H441 and H460 and induction of apoptosis was reported for nobiletin, 3, 5, 6, 7, 8, 3 0 ,4 0 -heptamethoxyflavone and 5-hydroxy-3,7,8,3
0 ,4 0 -pentamethoxyflavone isolated from a peel extract (Xiao, Yang, Li, et al., 2009) . Limonin and naringin produced by Citrus fruits displayed bone calcium concentration preservation and increased the antioxidant status in animal model (Mandadi, Ramirez, Jayaprakasha, et al., 2009) .
Conversely, however, very little is known about the pharmacological potential of secondary metabolites produced by seeds, leaves, roots and the bark of the Citrus species. In our ongoing investigation of the medical potential of plants of the Rutaceae family, several compounds isolated from the roots of C. reticulata have been reported to display strong oxidative burst inhibition and suppression of the phagocytosis response upon activation with serum opsonized zymosan in the range of 0.2-10.5 μM (Fomani, Ngeufa, Nouga, et al., 2016) . In continuation of our research on C. reticulata, this paper deals with the isolation, structure elucidation and pharmacological evaluation of secondary metabolites produced by its stem bark. C one-bond connectivities were determined with HSQC gradient pulse factor selection. Two-and three-bond connectivities were determined by HMBC experiments. Chemical shifts are reported in δ (ppm) using TMS as internal standard, and coupling constants (J) were measured in Hz. Column chromatography was carried out on silica gel (70-230 mesh, Merck). Thin layer chromatography (TLC) was performed on Merck precoated silica gel 60 F 254 aluminium foil, and spots were detected using ceric sulphate spray reagent. Phenolic compounds were detected using FeCl 3 reagent. The purity of the compounds was investigated by means of 1 H-NMR and ESIMS. The degree of purity of the positive control was ≥98%, while that of the isolated compounds was 95%. Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (Dorset, UK). Solvents were purchased from Fischer Scientific (Loughborough, UK). All cell culture reagents were purchased from Labtech International Ltd (East Sussex, UK). The human lung adenocarcinoma cell line A549, human breast adenocarcinoma cell line MCF7 and human Caucasian prostate adenocarcinoma cell line PC3 were purchased from the American Type Culture Collection (ATCC), 10801 University Blvd., Manassas, USA. The normal human prostate cell line PNT2 was obtained from the European Collection of Authenticated cell cultures (ECACC), (Salisbury, UK). All reagents used were of analytical grade.
MATERIALS AND METHODS

General
Plant material. Bark of C. reticulata was collected at the Batouri locality in Eastern Cameroon in December 2015 and identified by Mr. Nana Victor of the National Herbarium, Yaoundé, Cameroon, where a voucher specimen (25856SRF/Cam) was deposited.
Extraction and bioassay guided isolation. Soxhlet extraction of 1.2 kg of the air dried and powdered bark of C. reticulata yielded-after evaporation under reduced pressure-19.3, 25.4 and 38.2 g of n-hexane (Hex), dichloromethane (DCM) and methanol (MeOH) extract. Soxhlet extraction for each solvent was continued for ten cycles. The extracts were submitted to the MTT cytotoxicity/viability assay employing human cancer cell lines A549, MCF7, PC3 and normal cell PNT2. Tests were run in triplicate and activities compared with the positive control etoposide, a semisynthetic derivative of podophyllotoxin, a compound originating from the roots of Podophyllum peltatum (Berberidaceae). The Hex extract was found to be the most active against all three cancer cell lines and thus subjected to vacuum liquid chromatography (VLC) on TLC grade silica gel as the stationary phase. Elution was performed with mixtures of n-hexane and ethyl acetate (EA), namely 20% of EA in Hex, 50% of EA in Hex and 70% of EA in Hex to give three fractions, which were collected and evaporated under reduced pressure to obtain 2.5, 6.3 and 8.2 g, respectively. Subsequent MTT assays showed best results for the 70% of EA in Hex fraction, which was then submitted to column chromatography over silica gel 60 (230-400 mesh, 3.5 × 3.5 cm) using a gradient system of n-hexane and CH 2 Cl 2 . A total of 53 sub-fractions (ca. 100 mL each) were collected and pooled on the basis of TLC analysis leading to three series (A-C). Fraction A [1.5 g, combination of sub-fractions 1-15, eluted with a mixture of n-hexane-CH 2 Cl 2 (4:1)] yielded palmitic acid (18.2 mg) and lupeol (3) (21.5 mg), while fraction B [2.6 g, constituted by sub-fractions 16-31, eluted with a mixture of n-hexane-CH 2 Cl 2 (3:2)] led to β-amyrin (4) (11.2 mg), stigmasterol (5) (15.3 mg) and β-sitosterol (6) (16.4 mg). Fraction C [3.1 g, combination of sub-fractions 31-53, eluted with n-hexane-CH 2 Cl 2 (1:1) to 100% CH 2 Cl 2 ] gave scoparone (1) (15.5 mg) and xanthyletin (2) (8.1 mg) (Fig. 1) . Finally, compounds 1-6 were submitted to the MTT assay, and bioactivity results evaluated together with those previously received from crude extracts and fractions, in comparison to the positive control etoposide.
Scoparone (1): (Afek and Sztejnberg, 1988) . Xanthyletin (2): (Tillekeratne, De Silva, Mahindaratne, et al., 1989) . Lupeol (3): (Fomani et al., 2016) . β-amyrin (4): (Longue, Nouga, Fomani, et al., 2015) . Stigmasterol (5): (Fomani et al., 2016) . β-sitosterol (6): (Fomani et al., 2016) .
Cell lines, cell cultures and the 3-(4,5-dimethylthiazol-2-yl)-2,5-dphenyltetrazolium bromide assay. The potential cytotoxicity of C. reticulata stem bark extracts, their VLC fractions and the isolated compounds were studied against cancer cell lines A549 (human lung adenocarcinoma), MCF7 (human breast adenocarcinoma), PC3 (human prostate adenocarcinoma) and the normal cell line PNT2 (human prostate) using the MTT assay (Mosmann, 1983; Basar, Oridupa, Ritchie, et al., 2015) . All cell lines were cultured in RPMI-1640 medium supplemented with 10% foetal bovine serum and 1% antibiotic-antimycotic solution (100 ×). The cells were cultured at 37°C in 95% humidity and 5% CO 2 . For the MTT assays, the cells were washed using phosphate buffered saline and harvested by trypsinization. Cells were then seeded into 24 well plates at a density of 1.2 × 10 4 cells/well in a working volume of 1 mL/well and allowed to grow for 24 h before the commencement of each experiment. The cells were then treated for 24 h with different concentrations of test samples (the C. reticulata extracts and VLC fractions at 0, 0.8, 4, 20, 100, 500 μg/mL and the compounds at 0, 0.4, 2, 10, 50, 75 and 100 μg/mL). Dilution of stock solutions was made in culture medium yielding final sample concentrations with a final dimethyl sulfoxide (DMSO) concentration of 0.1%, including the control. Each sample concentration was used to treat four wells of cells in each 24-well plate. After the 24-h treatment period, the toxicity of the samples on each cell line was quantified. To achieve this, the medium in each well was replaced by MTT solution (500 μg/mL in medium) and incubated for 2 h. Viability of cells was assessed by their ability to reduce the yellow dye MTT to a blue formazan product (Popescu, Lupu, Raditoiu, et al., 2015) . The MTT reagent was removed, the formazan crystals were dissolved in isopropanol and the absorbance at 560 nm determined using a microplate reader (CLARIO Star Microplate Reader, BMG Labtech, UK). The average absorbance value obtained from zero treatment control (0.1% DMSO) wells was arbitrarily set at 100% for each plate, and the absorbance value for the average of wells of cells treated with each test sample concentration was expressed as a percentage of this control. Each assay was performed on a minimum of three separate occasions, and the IC 50 values for each sample on each cell line were calculated using Microsoft Excel version 2013. The anti-lung cancer drug etoposide was used as positive control.
Statistical analysis. All experiments were carried out in triplicate on separate occasions. Data were expressed as means ± standard error of the mean. The graphs were plotted using nonlinear regression with the use of Microsoft Excel version 2013.
RESULTS AND DISCUSSION
Soxhlet extraction of 1.2 kg of bark material of C. reticulata Blanco led-after evaporation under vacuum -to 19.32 g of Hex, 25.45 g of DCM and 38.16 g of MeOH extract. These extracts were tested against cancer cell lines A549, MCF7 and PC3, and normal cell line PNT2 using the MTT assay. Etoposide was used as positive control. While the MeOH extract was found to be inactive against above cancer cell lines, displaying IC 50 values >500 μg/mL, the DCM extract showed IC 50 values of (A549) 220.5, (MCF7) 54.7 and (PC3) 220.2 μg/mL, respectively. The Hex extract was the most active with IC 50 values of (A549) 100.2, (MCF7) 45.6 and (PC3) 100.5 μg/mL and was selected for fractionation by VLC technique. Three fractions, namely 20% of EA in Hex, 50% of EA in Hex and 70% of EA in Hex were obtained and submitted to MTT assay. The 20% of EA in Hex fraction resulted in IC 50 values of (A549) 210.3, (MCF7) 210.1 and (PC3) 445.4 μg/mL; the 50% fraction in (A549) 70.1, (MCF7) 205.5 and (PC3) 49.4 μg/mL and, most interestingly, the 70% of EA in Hex fraction in IC 50 values of (A549) 53.0, (MCF7) 52.4 and (A549) 49.1 μg/mL. The positive control etoposide delivered IC 50 values of (A549) 3.5, (MCF7) 10.2 and (PC3) 7.9 μg/mL, while the negative control consisting of media with DMSO did not display activity as was expected. It should be noted that the 70% of EA in Hex fraction is only 5-15 fold less active than the anticancer drug etoposide, depending on the cell line tested (Table 1; Figs. 2a-f, Supporting Information).
In the following, the 70% EA in Hex fraction was subjected to column chromatography on silica gel and preparative TLC to afford seven known compounds identified as scoparone (1), xanthyletin (2), lupeol (3), β-amyrin (4), stigmasterol (5), β-sitosterol (6) and Hex 100.2 ± 3.2 45.6 ± 1.2 100.5 ± 4.5 DCM 220.5 ± 2.4 54.7 ± 3.1 220.2 ± 1.8 MeOH >500 >500 >500 20% EA in Hex 210.3 ± 5.5 210.1 ± 3.6 445.4 ± 4.4 50% EA in Hex 70.1 ± 1.5 205.5 ± 2.5 49.4 ± 5.7 70% EA in Hex 53.0 ± 3.4 52.4 ± 3.6 49.1 ± 1.9 Etoposide 3.5 ± 0.5palmitic acid. (5) showed values of 21.1, 9.2 and 7.5 μg/mL, respectively. The latter values were comparable to those reported previously with 20.0, 8.8 and 7.8 μg/mL, respectively (Malek, Shin, Wahab, et al., 2009; Hsu, Huang, Lu, et al., 2011; Shen, Zhang, Wang, et al., 2012) . In addition, lupeol (3) A comparison of IC 50 values of crude extracts, fractions and isolated compounds clearly shows that the 70% EA in Hex fraction not only displays significant activities against cell lines A549, MCF7 and PC3, but is only around 3 times less active than scoparone (1) and stigmasterol (5), the two most active compounds reported here from this fraction. While the 70% EA in Hex fraction is in addition only 6 times less active than positive control etoposide against human prostate cancer cell line PC3, this fraction displayed low toxicity against the human normal prostate cell line PNT2 with IC 50 = 510.0 μg/mL, resulting in very favourable selectivity indices of 9.6, 9.7 and 10.4 μg/mL towards cell lines A549, MCF7 and PC3, respectively (Table 3) .
It should be mentioned that in natural products chemistry and pharmacology, a medicinal plant extract displaying inhibitory activity of IC 50 < 500 μg/mL is regarded as active, and IC 50 values of 300-400 μg/mL characterize an extract worth to identify its active ingredients. Interestingly, IC 50 values around 50 μg/mL determined for the 70% EA in Hex fraction combined with moderate to low activities in the IC 50 range of 7.5-97.2 μg/mL measured for secondary metabolites present in this fraction, strongly indicate synergistic effects.
Etoposide is used as one of the drugs of choice in the treatment of human lung adenocarcinoma and was shown here to give an IC 50 of 3.5 μg/mL against human lung cancer cell line A549, compared with the 70% EA in Hex fraction, 50% EA in Hex fraction and the hexane crude extract from the stem bark of C. reticulata showing IC 50 values of 53.0, 70.1 and 100.2 μg/mL, respectively.
CONCLUSIONS
In vitro assays show that the stem bark of C. reticulata widely used in Cameroon against tumours is probably a good crude drug treatment against lung, breast and prostate cancer when extracted with hexane and in addition against breast cancer when extracted with DCM. Moreover, first assays display very low toxicity of a hexane extract fraction against a human normal prostate cell line. However, additional in vitro and in vivo toxicity testing will be necessary, before a recommendation of above preparations can be given. A positive outcome might initiate formulation studies for the development of a safer anticancer plant product from the stem bark of this plant, to be manufactured in developing countries. While the anti-lung cancer drug etoposide is mostly given in combination therapy to reduce the therapeutical dosis, it is suggested that the 70% EA in hexane fraction from the stem bark of C. reticulata might turn out to be a candidate for supplemental treatment, subject to further investigation of its overall synergistic and biochemical mechanisms of action towards cancer cells as well as its toxicity in vivo.
